Magnetic micelles for DNA delivery to rat brains after mild traumatic brain injury

Nanomedicine. 2014 Oct;10(7):1539-48. doi: 10.1016/j.nano.2014.01.003. Epub 2014 Jan 29.

Abstract

Traumatic brain injury (TBI) causes significant mortality, long term disability and psychological symptoms. Gene therapy is a promising approach for treatment of different pathological conditions. Here we tested chitosan and polyethyleneimine (PEI)-coated magnetic micelles (CP-mag micelles or CPMMs), a potential MRI contrast agent, to deliver a reporter DNA to the brain after mild TBI (mTBI). CPMM-tomato plasmid (ptd) conjugate expressing a red-fluorescent protein (RFP) was administered intranasally immediately after mTBI or sham surgery in male SD rats. Evans blue extravasation following mTBI suggested CPMM-ptd entry into the brain via the compromised blood-brain barrier. Magnetofection increased the concentration of CPMMs in the brain. RFP expression was observed in the brain (cortex and hippocampus), lung and liver 48 h after mTBI. CPMM did not evoke any inflammatory response by themselves and were excreted from the body. These results indicate the possibility of using intranasally administered CPMM as a theranostic vehicle for mTBI. From the clinical editor: In this study, chitosan and PEI-coated magnetic micelles (CPMM) were demonstrated as potentially useful vehicles in traumatic brain injury in a rodent model. Magnetofection increased the concentration of CPMMs in the brain and, after intranasal delivery, CPMM did not evoke any inflammatory response and were excreted from the body.

Keywords: Bio-distribution; Brain; DNA delivery; LFPI; Magnetic micelle; TBI; Theranostic.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Brain Injuries / therapy*
  • Cell Line
  • Contrast Media
  • DNA / administration & dosage*
  • Magnetic Resonance Imaging
  • Magnetics*
  • Male
  • Micelles*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Contrast Media
  • Micelles
  • DNA